Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2021-08-25
2029-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
NCT01330342
Tissue Biopsy and Imaging Studies in HIV-Infected Patients
NCT00001471
Viral Load in Blood and Lymph Tissues in People Living With HIV
NCT00001316
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
NCT05510908
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
NCT01202305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV-infection at time of lymphoma diagnosis
* Lymphoma diagnosis since 01.01.2010
* Adult patients ≥ 18 years
* Written informed consent
Exclusion Criteria
* Non-Compliance or lack of opportunity for follow-up (for the prospective part of the study)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rotkreuzklinikum München gGmbH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Marcus Hentrich
Head of the Department of Hematology and Oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcus Hentrich, MD
Role: STUDY_CHAIR
Rotkreuzklinikum München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Red Cross Hospital Munich
Munich, Select One Option, Germany
University Hospital Cologne
Cologne, , Germany
Amsterdam University Medical Centers
Amsterdam, , Netherlands
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hospital Universitario de Salamanca
Salamanca, , Spain
University Hospital of Wales
Cardiff, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sanne Tonino, MD, PhD
Role: primary
Role: backup
Isabel Regalado Artamendi
Role: primary
Role: backup
Emily Hopkins, MD
Role: primary
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IN03/0121
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.